February 20, 2023
Patented (Symbiosis, Inc.)
We are pleased to announce that we have been granted a patent for “Composition Containing Biological Microorganisms and Method for Producing the Same,” for which an application was filed by Symbiosis, Inc. Patent Information [Patent No.] Patent No. 7104435 [Title of Invention] “Composition Containing Biological Microorganisms and Method for Making the Composition […
December 16, 2022
U.S. FDA approves first fecal microbiota product
On November 30, 2022, the U.S. Food and Drug Administration (FDA) approved FerringPharma’s fecal microbiota product, Rebyota, for the treatment of rCDI, the first time the FDA has approved a fecal microbiota product […
October 05, 2022
The 6th Annual Conference [Report]
The 6th Annual Scientific Meeting, held on Sunday, September 18, 2022, was held simultaneously at the venue and online. It was attended by many people, including medical professionals, general business people, people from research institutions, patients, and the general public. Despite the corona pandemic, everyone […]
July 11, 2022
Thank You for Achieving Crowdfunding Goal
The crowdfunding project “We want to provide children with autism spectrum disorder with treatment that opens up a bright future” that started on Saturday, May 14, 2022, ended at 23:59 on Sunday, July 10, 2010. Thanks to your support, we have reached our goal of […].
June 20, 2022
Patented (Symbiosis, Inc.)
We are pleased to announce that we have filed applications for “bubble shear filter, ultrafine bubble generator, and method for producing ultrafine bubble fluid” and “rotating mixer, ultrafine bubble generator, and ultrafine bubble […]” from Synbiosis, Inc.
April 27, 2022
The review for accreditation as a “compliant organization for medical safety evaluation” has been completed.
AS A “PHYSICIAN-GUIDED CLINICAL TRIAL”, OUR RESEARCH GROUP HAS CONDUCTED INTESTINAL FLORA TRANSPLANTATION (FECAL MICROBIOTA TRANSPLANTATION = FMT) FOR THE FIRST TIME IN JAPAN IN 2017 AT A PRIVATE MEDICAL INSTITUTION IN AN ORGANIZED MANNER TO ESTABLISH A NEW MEDICAL TREATMENT. The patients who received intestinal flora transplants, which had not yet been established as […]
February 19, 2022
Received the Chancellor’s Award at the 3rd Founding Business Contest [Symbiosis, Inc.]
We are pleased to announce that Symbiosis, Inc. participated in the “3rd Business Plan Contest for Start-up Businesses” sponsored by the Osaka Shinkin Bank. Seven companies were selected out of 135 applicants, and the final judging was held on Thursday, February 17. The results are as follows in the Founding Division ＼ The President’s Award […]
November 10, 2021
[THE 5TH ANNUAL CONFERENCE] INTERVIEW (MR. KAZUNARI ISHIDA, SOPHIA CO., LTD.)
Innovations brought about by intestinal flora transplantation to realize “Symbiosis with Bacteria CORPORATE SUPPORTING MEMBER MR. KAZUNARI ISHIDA, SOPHIA CORPORATION SOPHIA CO., LTD. MANUFACTURES SUPPLEMENTS MADE FROM LACTOBACILLI AND OTHER INGREDIENTS AND RAW MATERIALS WITH THE MISSION OF SPREADING THE “WISDOM OF HEALTH AND LONGEVITY” FROM ALL OVER THE WORLD AND APPLYING IT TO THE […]
October 22, 2021
【Report vol.6】5th Annual Conference NanoGAS® Water Research Report
Report on the 5th Annual Meeting ＜vol.6＞ “Research on the Application and Practical Use of Ultra Fine Bubble NanoGAS® in the Medical Field” Risako Morishita, Symbiosis Research Institute Synbiosis reported on the NanoGAS® Water study. NanoGAS®, which is utilized for intestinal flora transplantation (FMT), has an excellent track record in the treatment of a wide […]
October 15, 2021
[The 5th Annual Conference] Interview with Ai Kitamura, President, Love I Food Education, Inc.
Expectations for the value-added possibilities of intestinal flora transplants that lead to fermented foods”. Corporate Supporting Member General Incorporated Association Love I Food Education Representative Director Ms. Ai Kitamura Fermented foods have been booming in recent years and are expected to have an effect on the intestinal microflora. We interviewed Ms. Ai Kitamura, a fermented […]
